Designing Peptide Mimetics for the Treatment of Multiple Sclerosis

Author(s): J. Matsoukas, V. Apostolopoulos, T. Mavromoustakos

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 1 , Issue 3 , 2001

Become EABM
Become Reviewer
Call for Editor


Multiple sclerosis is a chronic inflammatory disease of the central nervous system. While the molecular basis of the disease is still unknown, research effort is currently under progress to prevent or ameliorate its effects. There are two major approaches currently in the pursuing of improved therapeutics for the treatment of multiple sclerosis. The first approach focuses on peptide or mimetic therapy and the second on immunotherapy by preventing or controlling disease through the release of appropriate cytokines.

Keywords: Multiple Sclerosis, Autoimmunity, Corticosteroids, Cytokines, Cytotoxic immunosuppressants, Antidepressants (SSRIs), Mannan Conjugates

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2001
Page: [273 - 282]
Pages: 10
DOI: 10.2174/1389557013406873
Price: $65

Article Metrics

PDF: 3